TrialClinical pharmacokinetics2017

Comparison of a Novel Formulation of Abiraterone Acetate vs. the Originator Formulation in Healthy Male Subjects: Two Randomized, Open-Label, Crossover Studies.

Ronald Goldwater et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.